FAQs for HCP segment New Instructions for Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Non-Adjunctive Indication
|
|
- Agnes Owen
- 6 years ago
- Views:
Transcription
1 FAQs for HCP segment New Instructions for Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Non-Adjunctive Indication Q1. The Dexcom G5 Mobile System is the first CGM System to receive FDA approval to make CGMbased treatment decisions ("non-adjunctive use"). What does this new indication mean? It means the Dexcom G5 Mobile can now be used to make diabetes treatment decisions without confirming the reading with a blood glucose meter.* Previously, all CGM devices were indicated for use only as a complement (adjunct), not a replacement, for blood glucose meters. *Fingersticks required for calibration, or if symptoms or expectations do not match readings, or when taking medications containing acetaminophen. Q2. Does this non-adjunctive indication apply to both adult and pediatric patients? Yes, the new indication is approved for both adult and pediatric users (as young as two years of age) of the Dexcom G5 Mobile. Q3. Is the non-adjunctive indication for CGM-based treatment decisions approved for the Dexcom G4 Professional System? No, making treatment decisions with CGM is approved only for personal use and only for the Dexcom G5 Mobile. Q4. Does the non-adjunctive indication for CGM-based treatment decisions apply to Dexcom CGMintegrated insulin pumps? No, patients should not make CGM-based treatment decisions using the Animas and Tandem insulin pumps that are integrated with any Dexcom CGM systems. These integrated pump systems are not currently approved for non-adjunctive use. Patients on insulin pump therapy would need to use the standalone Dexcom G5 Mobile (including the G5 Transmitter) to make treatment decisions. Q5. If patients are currently using a previous-generation System to the Dexcom Mobile G5 CGM System (such as the Dexcom G4 PLATINUM System with Share), can they use it to make treatment decisions? No, the non-adjunctive indication is only approved for the Dexcom G5 Mobile. Other algorithms and user interfaces have not been approved. Patients can easily recognize if they have the Dexcom G5 Mobile because they will be using either the Dexcom G5 Mobile App or the Dexcom G5 Mobile Receiver that has a screen with a white background, similar to the app's white background. Q6. Does this new indication eliminate the need for fingersticks? No. Two fingersticks per day (once every 12 hours) are still needed to calibrate Dexcom G5 Mobile. Additionally, there are important exceptions that require the use of a meter to make treatment decisions, including: Their Dexcom G5 Mobile Receiver or compatible smart device* is not showing both a glucose reading and a directional arrow. Both of these pieces of information must be displayed. Patient symptoms or expectations don t match the CGM reading if they are experiencing symptoms of hypoglycemia or hyperglycemia, they should use a meter before making a treatment decision.
2 Patients have taken medications containing acetaminophen The revised instructions allow for CGM-based treatment decisions, but they do not require it. Patients who prefer to use CGM as a complement to SMBG may continue to do so. For some users, it might take a little time to become comfortable with CGM-based treatment decisions. Others may choose to use it at certain times (e.g., night) and not at others (e.g., immediately after a new sensor is inserted). *To view a list of compatible devices, visit dexcom.com/compatibility Q7. Has anything changed in the Dexcom G5 Mobile CGM System with this new indication? Nothing has changed in the components, accuracy or functionality of the System. We have only revised the instructions to include CGM-based treatment decisions. Q8. Are there times when patients will still need to use a meter to make treatment decisions? Yes, patients will still need to use a meter to calibrate the Dexcom G5 Mobile every 12 hours. Additionally, there are important exceptions to using the System to make treatment decisions. Please advise your patients that they must use a meter to make treatment decisions in the following situations: Their Dexcom G5 Mobile Receiver or compatible smart device* is not showing both a glucose reading and a directional arrow. Both of these pieces of information must be displayed. Their symptoms or expectations don t match the CGM reading if they are experiencing symptoms of hypoglycemia or hyperglycemia, they should use a meter before making a treatment decision. They have taken medications containing acetaminophen. The revised instructions allow for CGM-based treatment decisions, but they do not require it. Patients who prefer to use CGM as a complement to SMBG may continue to do so. For some users, it might take a little time to become comfortable with CGM-based treatment decisions. Others may choose to use it at some times (e.g., night) and not at others (e.g., immediately after a new sensor is inserted). *To view a list of compatible devices, visit dexcom.com/compatibility Q9. Will this indication impact the way glucose data that is shared via the Dexcom G5 Mobile app? No, the non-adjunctive indication does not change the nature or display of CGM data to a user s family, friends or caregivers ( Followers ). Remember that treatment decisions should not be made based on Dexcom Follow. Treatment decisions should be made based on the reading from Dexcom G5 Mobile or a blood glucose meter. The Follower may contact the patient to ask them to confirm their CGM reading before providing advice or guidance (e.g., Mom texts daughter, "Follow says you are low. What reading does your CGM show?"). Q10. What data supports CGM-based treatment decisions? Existing clinical performance data 1 supports an accuracy level of the Dexcom G5 Mobile that is approaching the accuracy of some blood glucose monitors. Additionally, computer simulation studies confirmed outcomes from non-adjunctive use were equivalent to outcomes when decisions were based on blood glucose measurements. 2
3 Q11. Why is this new indication important to me? This indication is approved by the FDA. The updated instructions now provide a framework for you to properly educate and train your patients about using the Dexcom G5 Mobile as the primary tool for making appropriate treatment decisions to optimize their treatment. Q12. How will patients be informed of the new instructions for CGM-based dosing? Dexcom G5 Mobile CGM Systems will be updated with a revised Getting Started Guide, tutorial (USB insert), as well as abbreviated instructional inserts sheets in both sensor and receiver kits. The inserts will also be included in sensor re-order boxes. Patients may train with their HCP using the instruction sheet, or they may choose to self-train with the Getting Started Guide, tutorial or full User Guide (available at dexcom.com/guides). Existing patients (with a confirmed ) who had already purchased the G5 Mobile System will be notified via and postal mail about the new indication and will receive sensor re-orders with the abbreviated instructional inserts. Q13. What should I communicate to my patients? You should communicate: 1. A blood glucose meter should still be used to make treatment decisions under any of the these circumstances: The patients Dexcom G5 Mobile CGM Receiver or compatible smart device* is not displaying both a glucose reading and a directional arrow. Their symptoms or expectations do not match the CGM reading They have taken medications containing acetaminophen. 2. For System calibration - a fingerstick is required every 12 hours to calibrate the Dexcom G5 Mobile CGM System. 3. Additionally, it is important to review the following with them: Avoid insulin stacking (taking insulin doses too close together) Proper fingerstick technique especially to ensure accurate calibrations To trust their instincts; in other words, When in doubt, get your meter out. 4. Inform them they can still use a meter to confirm treatment decisions if they are more comfortable doing so. Q14. What resources are available to help me educate patients about this new indication? To familiarize yourself with the non-adjunctive indication, please review the HCP Non-Adjunctive Training slide deck a comprehensive web-based presentation to help guide patient communication as well as help you understand how the System can be used to make treatment decisions. You may also refer to two other training tools the Dexcom G5 Mobile Treatment Decisions (The Basics) and the Dexcom G5 Mobile Treatment Decisions (Advanced). You can review the Basics handout with your patients, while the Advanced guide is designed specifically for clinicians to educate them about how the rate-of-change arrows can be used to guide treatment decisions.
4 Your patients will also receive basic instructions and a tutorial (USB card) in product shipments, and you can also direct them to dexcom.com/guides for additional resources. Q15. Some patients have expressed concern that their Dexcom CGM readings are sometimes very different from their meter. How can I ease their concerns about using the Dexcom G5 Mobile CGM System non-adjunctively? CGM is based on trends - not a single number. The continuous information provides a real-time, dynamic view of one s glucose to facilitate better management decisions. To optimize the use of the Dexcom G5 Mobile: Patients should be reminded of proper fingerstick technique so they will use their "best" fingersticks for calibrating. Patients need to understand that fingersticks are not always accurate, despite their long history. Advise patients to consider taking a second fingerstick when their CGM and first fingerstick do not match. Remind patients they are not required to use the Dexcom G5 Mobile to make treatment decisions; they may still use their meter for their diabetes management. Q16. If I have questions, whom should I contact? If you have questions, please contact Dexcom CARE, our team of certified diabetes educators and other healthcare professionals, at (ext.4950) or patientcare@dexcom.com; your local sales rep; or visit hcp.dexcom.com. Q17. Is there dosing guidance for HCPs? Dexcom does not provide dosing guidance for HCPs. There are, however, there are three approaches to using the rate-of-change arrows to adjust insulin doses. These are: 1. DirecNet Method Use of the DirecNet Applied Treatment Algorithm (DATA) for Diabetes Management with a Real-Time Continuous Glucose Monitor (the FreeStyle Navigator). Pediatr Diabetes Apr; 9(2): Jeremy Pettus and Steven Edelman Method Recommendations for using Real-Time Continuous Glucose Monitoring (rtcgm) Data for Insulin Adjustments in Type 1 Diabetes. Journal Diabetes Science and Technology. August Gary Scheiner Method Practical CGM: Guide to Improving Outcomes Through Continuous Glucose Monitoring. American Diabetes Association, BRIEF SAFETY STATEMENT The Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System ( G5 ) is a glucose monitoring system indicated for detecting trends and tracking patterns in persons (age 2 years and older) with diabetes. CONTRAINDICATIONS Do not rely on the G5 CGM data if you have recently taken acetaminophen. Remove the System (sensor, transmitter, and receiver) before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment. The System is MR Unsafe. Do not bring any portion of the System into the MR environment. WARNING CGM-based diabetes treatment decisions are only approved with the G5, not previous generations. Calibrate at least once every 12 hours using a
5 fingerstick. If your G5 does not display a sensor glucose reading and an arrow, or if you are getting inaccurate or inconsistent readings, take a fingerstick. If your glucose readings and alerts do not match your symptoms or expectations, take a fingerstick to confirm. Failure to do so may lead to hyperglycemia or hypoglycemia. The System is not approved for use in pregnant women, persons on dialysis or critically ill persons. If a sensor breaks and no portion of it is visible above the skin, do not attempt to remove it. Seek professional medical help if you have infection or inflammation. Report broken sensors to Dexcom Technical Support. Sensor placement is not approved for sites other than under the skin of the belly (ages 2 years and older) or upper buttocks (ages 2-17 years). To share data, you need an internet connection and a separate smart device running the Dexcom Follow App. Contact Dexcom Toll Free at or for detailed indications for use and safety information. References 1. Bailey TS, Chang A, Christiansen M. Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol. 2015;9(2): Dexcom G5 Mobile Continuous Glucose Monitoring System FDA Advisory Panel Committee Briefing Materials, presented July 21, 2016, Washington, DC. Available at: aldevicesadvisorycommittee/clinicalchemistryandclinicaltoxicologydevicespanel/ucm h tml. Accessed July 21, 2016.
Receiver and App Setup
Continuous Glucose Monitoring System Receiver and App Setup For training videos visit dexcom.com/medicare Overview Your Dexcom G5 Continuous Glucose Monitoring (CGM) System is made up of: Transmitter (Sensor
More informationContinuous Glucose Monitoring System. Receiver Setup
Continuous Glucose Monitoring System Receiver Setup Overview Your Dexcom G5 Continuous Glucose Monitoring (CGM) System is made up of: Receiver What do I do with it? Review your readings. Set and receive
More informationFirst steps for success.
First steps for success. Getting to know continuous glucose monitoring (CGM). The Animas Vibe System is approved for persons age 2 and older. Important Safety Information The Animas Vibe Insulin Pump and
More informationSeven Simple Steps to Start. Your Dexcom G4 PLATINUM System
Seven Simple Steps to Start Your Dexcom G4 PLATINUM System Receiver Sensor Applicator Transmitter Sensor Remove transmitter from tray and wait 10 minutes Do Not Throw Away Battery life ~ 6 months Charging
More informationNext steps for success.
Next steps for success. More tips for using CGM* training course. The Animas Vibe System is approved for persons age 2 and older. *Continuous Glucose Monitoring Important Safety Information The Animas
More informationInsert your sensor and attach the Transmitter (see pg5-6. Enter 2 calibrations after 2 hour start up period (5 min apart with BG meter)
1 Dexcom Start Date: Receiver out of Warranty (12months): Transmitter out of Warranty (6months): Your high alert is set at: Your low alert is set at: Date of return to clinic: CGM is a tool that tracks
More informationQuick Reference Guide
FLASH GLUCOSE MONITORING SYSTEM Quick Reference Guide IMPORTANT USER INFORMATION Before you use your System, review all the product instructions and the Interactive Tutorial. The Quick Reference Guide
More informationQuick Reference Guide
FLASH GLUCOSE MONITORING SYSTEM Quick Reference Guide FreeStyle LibreLink app A FreeStyle Libre product IMPORTANT USER INFORMATION Before you use your System, review all the product instructions and the
More informationQuick Reference Guide
FLASH GLUCOSE MONITORING SYSTEM Quick Reference Guide IMPORTANT USER INFORMATION Before you use your System, review all the product instructions and the Interactive Tutorial. The Quick Reference Guide
More informationAbbott FreeStyle Libre Pro System
, the Professional CGM Abbott FreeStyle Libre Pro Reader Kit includes: Reader, USB cable, interactive tutorial on USB, and power adapter, user s manual, Quick Start Guide, Quick Reference Guide Kit includes:
More informationA pump for every body.
A quick look at Animas Vibe A pump for every body. Even for the most insulin sensitive. Every body needs accuracy. Here s why: For anyone with diabetes, having the right amount of insulin at just the right
More informationShare/Follow. User Guide. A feature of Dexcom G5 Mobile CGM System
Share/Follow User Guide A feature of Dexcom G5 Mobile CGM System IMPORTANT USER INFORMATION Please review your product instructions before using your continuous glucose monitoring system. Contraindications,
More informationQuick Reference Guide. Sensor Smart Transmitter Mobile App
Quick Reference Guide Sensor Smart Transmitter Mobile App Refer to the Eversense CGM User Guide for more detailed information. For a Spanish version of the User Guide and Quick Reference Guide, please
More informationLBL Rev 001. School Guide
School Guide LBL015393 Rev 001 Introduction Welcome to the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) School Guide. The purpose of this guide is to define CGM, explore the differences between
More informationDexcom Current and Future Technology Innovations. Jorge Valdes Chief Technical Officer
Dexcom Current and Future Technology Innovations 2015 Jorge Valdes Chief Technical Officer G5 App Sensor (Same as G4) Indicated for adults and children down to Age 2 years Tiny insertion needle (26Ga)
More informationInformation Overload! CGM, Navigating for Success. Presented by: Kathi Milton RD, CDE and Amy Foreman RN, CDE
Information Overload! CGM, Navigating for Success Presented by: Kathi Milton RD, CDE and Amy Foreman RN, CDE CGM-What is it? Continuous Glucose Monitor: a device that provides measurement of glucose data,
More informationAbbott FreeStyle Libre Pro System
Professional CGM Abbott FreeStyle Libre Pro Reader Kit includes: Reader, USB cable, interactive tutorial on USB, and power adapter, user s manual, Quick Start Guide, Quick Reference Guide Kit includes:
More informationUsing Your G6. Welcome Home Screen Overview Alarm and Alerts Treatment Decisions Ending Your Sensor Session Appendices
Using Your G6 Welcome Home Screen Overview Alarm and Alerts Treatment Decisions Ending Your Sensor Session Appendices WARNING: Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and
More informationGLOOKO DREAMED FOR ANDROID USER GUIDE
GLOOKO DREAMED FOR ANDROID USER GUIDE November 2018 IFU-0017 02 TABLE OF CONTENTS TABLE OF CONTENTS GENERAL INFORMATION... 2 Product Description... 2 Glooko Intended Use... 2 Dreamed Intended Use... 2
More informationCONTINUOUS GLUCOSE MONITORING SYSTEM. Receiver with Share TM USER S GUIDE
CONTINUOUS GLUCOSE MONITORING SYSTEM Receiver with Share TM USER S GUIDE USER S GUIDE DEXCOM G4 PLATINUM (PEDIATRIC) CONTINUOUS GLUCOSE MONITORING SYSTEM RECEIVER WITH Share TM IMPORTANT CONTACTS AND
More informationUsing Your G6. Welcome Home Screen Overview Alarm and Alerts Treatment Decisions Ending Your Sensor Session Advanced App Features Appendices
Using Your G6 Welcome Home Screen Overview Alarm and Alerts Treatment Decisions Ending Your Sensor Session Advanced App Features Appendices Instructions For Use Table of Contents Chapter 1: Welcome!...2
More information1 Dexcom G4 Platinum User Guide May 2012
1 Dexcom G4 Platinum User Guide May 2012 Page 1. Dexcom G4 PLATINUM Continuous Glucose Monitoring System. CE marked for use in 1Dexcom G4 User Guide, May 2012. LBL-011277 Rev04. color display. Dexcom G4
More informationNEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP
NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP No commercial support or sponsorship was received for this project I have nothing to disclose OBJECTIVES Identify at
More informationContinuous Glucose Monitoring
Continuous Glucose Monitoring Information about fully-subsidised continuous glucose monitoring for children and young people with type 1 diabetes Continuous glucose monitoring (CGM) can help in managing
More informationToday s Goals 10/6/2017. New Frontiers in Diabetes Technology. Disclosures
New Frontiers in Diabetes Technology Marie E. McDonnell, MD Director, Brigham and Women's Diabetes Program Division of Endocrinology, Diabetes and Hypertension Brigham and Women s Hospital Today s Goals
More information10:20 AM March 5, B 100% 235 u. 124 mg/dl 3 HRS INSULIN ON BOARD:
DEXCOM G5 MOBILE CGM COMPATIBLE B 100% 235 u INSULIN ON BOARD: OPTIONS 10:20 AM March 5, 2017 400 350 300 250 200 150 100 50 1.1 u 1:09 hrs BOLUS 124 mg/dl 3 HRS The pump that gets updated, not outdated.
More informationPredicts and helps prevent lows with. zero fingersticks NOW FEATURING BASAL-IQ TECHNOLOGY
Predicts and helps prevent lows with * zero fingersticks NOW FEATURING BASAL-IQ TECHNOLOGY Basal-IQ Technology is not a substitute for active self-management of your diabetes. Please see back cover for
More informationGetting Started Guide
Getting Started Guide for Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Dexcom G5 Mobile CGM System Getting Started Guide 1 2 Dexcom G5 Mobile CGM System Getting Started Guide Table of Contents
More informationCorporate Medical Policy
Corporate Medical Policy Continuous Monitoring of Glucose in the Interstitial Fluid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: continuous_monitoring_of_glucose_in_the_interstitial_fluid
More informationRELEASED. Clearing your active insulin
To clear all your settings: 1. Make sure the pump is not connected to your body. 2. Go to the Manage Settings screen. Menu > Utilities > Manage Settings 3. Simultaneously press and hold and until the Manage
More informationUsing Your G6. Welcome Home Screen Overview Alarm and Alerts Treatment Decisions Ending Your Sensor Session Advanced App Features Appendices
Using Your G6 Welcome Home Screen Overview Alarm and Alerts Treatment Decisions Ending Your Sensor Session Advanced App Features Appendices Instructions For Use Table of Contents Chapter 1: Welcome!...
More informationDiabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)
Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) 9501366-011 20110401 Objectives Understand the need for insulin pumps and CGMS in managing
More informationGetting Started. with Continuous Glucose Monitoring. Learning Guide
Getting Started with Continuous Glucose Monitoring Learning Guide Getting Started with Continuous Glucose Monitoring Keys to Success Getting Started with CGM: Learning Guide TRENDS CGM finally lets you
More informationCONTINUOUS GLUCOSE MONITORING SYSTEM. Quick Start Guide
CONTINUOUS GLUCOSE MONITORING SYSTEM Quick Start Guide Quick Start Guide Congratulations on making the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System part of your life! The Dexcom G5 Mobile
More informationAnimas Vibe System World-class insulin pumping meets world-class CGM*
Animas Vibe System World-class insulin pumping meets world-class CGM* Fully integrated with Dexcom G4 PLATINUM CGM* *Continuous glucose monitoring. My Animas pump has really put me in the driver s seat
More informationNDSS Helpline
Continuous GLUCOSE MONITORING A guide to using CGM for children and young people with type 1 diabetes NDSS Helpline 1300 136 588 ndss.com.au The National Diabetes Services Scheme is an initiative of the
More informationOptimizing Therapy and Clinical Outcomes Using Real-Time Continuous Glucose Monitoring (AADE PRODUCT THEATRE) August 7, 2014 Orlando, FL
Optimizing Therapy and Clinical Outcomes Using Real-Time Continuous Glucose Monitoring (AADE PRODUCT THEATRE) August 7, 2014 Orlando, FL Welcome and Introduction Orlando, FL August 7 th, 2014 Keri Weindel,
More informationWhen Will CGM Replace SMBG? Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida
When Will CGM Replace SMBG? Roy W. Beck, MD, PhD JAEB Center for Health Research Tampa, Florida Financial Disclosures Dr. Beck does not have any personal conflicts of interest His employer, the JAEB Center
More informationGetting Started Guide
Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Getting Started Guide Dexcom G5 Mobile CGM System Getting Started Guide 1 Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Getting
More informationPOPULATION TRACKER MIDS USER GUIDE
POPULATION TRACKER MIDS USER GUIDE December 2018 IFU-0003 14 TABLE OF CONTENTS TABLE OF CONTENTS... 1 Intended Use... 1 Warnings... 1 Contraindications... 1 Compatible Browsers... 2 Treatment Plan Templates
More informationThe Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes
The Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes Sarah Dombrowski, PharmD, BCACP Pennsylvania Pharmacists Association 10/20/18 1 Objectives At the completion of this activity,
More informationThe Realities of Technology in Type 1 Diabetes
The Realities of Technology in Type 1 Diabetes May 6, 2017 Rosanna Fiallo-scharer, MD Margaret Frederick, RN Disclosures I have no conflicts of interest to disclose I will discuss some unapproved treatments
More informationINSPIRED BY GIVE HER MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs.
INSPIRED BY GIVE HER MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs. * NOW APPROVED FOR AGES 7 AND UP. MORE TIME HERE TO USING
More informationCONTINUOUS GLUCOSE MONITORING SYSTEM. Quick Start Guide
CONTINUOUS GLUCOSE MONITORING SYSTEM Quick Start Guide Table of Contents Section 1: Welcome...4 1.1 Learning How to Learn...4 Section 2: Indications for Use and Safety Statement...5 Section 3: Risks and
More informationDiabetes Technology Update. Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018
Diabetes Technology Update Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018 Disclosures None No future technologies are FDA approved Continuous Glucose Monitors Continuous Glucose Monitors
More informationG5 Mobile System User Guide. Glossary
G5 Mobile System User Guide Glossary 1 Table of Contents Chapter 1... 14 Beginning Your Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Journey... 14 1.1 Introduction... 14 1.2 Self-Paced Resources...
More informationInsulin Pumps and Continuous Glucose Sensors- Embracing Technology. Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education
Insulin Pumps and Continuous Glucose Sensors- Embracing Technology Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education Diabetes Management Tools in 1974 Insulin pump history
More informationCONTINUOUS OR INTERMITTENT GLUCOSE MONITORING IN INTERSTITIAL FLUID
FLUID Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent
More informationWelcome to Your FreeStyle Libre System
Welcome to Your FreeStyle Libre System IN-SERVICE GUIDE See Indications and Important Safety Information inside. Important Safety Information Indications For Use The FreeStyle Libre Flash Glucose Monitoring
More informationUSER S GUIDE DEXCOM G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM
USER S GUIDE DEXCOM G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM IMPORTANT CONTACTS AND NUMBERS Dexcom Website: www.dexcom.com Your Transmitter ID: Your Receiver ID: Your Healthcare Professional: Nearest
More informationMedtronic MiniMed Insulin Infusion Pumps
Medtronic MiniMed Insulin Infusion Pumps Patients should always discuss potential risks and benefits with a physician. Please review the product manual prior to use for detailed instructions and disclosure.
More informationUser s Manual FLASH GLUCOSE MONITORING SYSTEM. CAUTION: Federal law restricts this device to sale by or on the order of a physician.
User s Manual FLASH GLUCOSE MONITORING SYSTEM CAUTION: Federal law restricts this device to sale by or on the order of a physician. Your Name Important Safety Information... 1 Indications For Use.......................................
More informationData Management System (DMS) User Guide
Data Management System (DMS) User Guide Eversense and the Eversense logo are trademarks of Senseonics, Incorporated. Other brands and their products are trademarks or registered trademarks of their respective
More information1. Continuous Glucose Monitoring
1. Continuous Glucose Monitoring 1. Physiology of interstitial fluid glucose 2. Comparison of CGM and self-monitored blood glucose (SMBG) data 3. Insulin dosing indication in BGM vs. CGM & the FDA 4. Protection
More informationAdvances in Diabetes Care Technologies
1979 Advances in Diabetes Care Technologies 2015 Introduction Insulin pump use: ~ 20% - 30% of patients with T1DM < 1% of insulin-treated patients with T2DM 2007 FDA estimates ~375,000 insulin pumps for
More informationCONTINUOUS GLUCOSE MONITORING SYSTEM. Receiver with Share TM USER S GUIDE
CONTINUOUS GLUCOSE MONITORING SYSTEM Receiver with Share TM USER S GUIDE USER S GUIDE DEXCOM G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM RECEIVER WITH Share TM IMPORTANT CONTACTS AND NUMBERS Dexcom
More informationADVANCES IN DIABETES TECHNOLOGY: A FOCUS ON CONTINUOUS GLUCOSE MONITORING 9:15 10:15 AM
ADVANCES IN DIABETES TECHNOLOGY: A FOCUS ON CONTINUOUS GLUCOSE MONITORING 9:15 10:15 AM ACPE UAN: 0107-9999-18-124-L01-P 0.1 CEU/1 hr Activity Type: Knowledge-Based Learning Objectives for Pharmacists:
More informationDIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson
DIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson March 3 rd, 2018 Who is this guy? Accelerating Progress 1 Oh that guy! Accelerating Progress 2 STATE OF T1D CARE
More informationRELEASED. first steps. Icon Icon name What it means
Icon Icon name What it means Connection The connection icon appears green when the Sensor feature is on and your transmitter is successfully communicating with your pump. The connection icon appears gray
More informationContinuous Glucose Monitoring (CGM) Dexcom G6 Training for Healthcare Professionals and Patients
ssociation of Children s Diabetes Continuous Glucose Monitoring (CGM) Dexcom G6 Training for Healthcare Professionals and Patients 1 ssociation of Children s Diabetes Contents Chapter Page no. Chapter
More informationconfidently live life with ease Management Presentation
confidently live life with ease Management Presentation 1 Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that could cause
More informationObjectives. Glucose Monitoring Today. Tracking Glucose ISO Standards. Continuous Glucose Monitoring & Diabetes Management 3/7/2015
Objectives Continuous Glucose Monitoring & Diabetes Management Tomas C. Walker, DNP, APRN, CDE Director, Clinical Projects Dexcom, Inc. San Diego, CA 1. Review current limitations of SMBG 2. Understand
More informationState of California Health and Human Services Agency Department of Health Care Services
State of California Health and Human Services Agency Department of Health Care Services JENNIFER KENT Director EDMOND G. BROWN JR Governor DATE: N.L.: 03-0317 Index: Benefits TO: ALL COUNTY CALIFORNIA
More informationOneTouch Reveal Web Application. User Manual for Healthcare Professionals Instructions for Use
OneTouch Reveal Web Application User Manual for Healthcare Professionals Instructions for Use Contents 2 Contents Chapter 1: Introduction...4 Product Overview...4 Intended Use...4 System Requirements...
More informationMEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps
POLICY: PG0177 ORIGINAL EFFECTIVE: 12/01/08 LAST REVIEW: 05/24/18 MEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps GUIDELINES This policy does not certify benefits or authorization
More informationUser Guide. A guide for using the Eversense Continuous Glucose Monitoring System. Sensor Smart Transmitter Mobile App
User Guide A guide for using the Eversense Continuous Glucose Monitoring System Sensor Smart Transmitter Mobile App LBL-0202-01-001 Rev 1_Eversense User Guide_mgdL_R6.indd 1 7/22/16 11:38 AM LBL-0202-01-001
More informationLive life, less complicated. InPen MOBILE APP. Healthcare Provider INSTRUCTIONS FOR USE. CompanionMedical.com
InPen MOBILE APP Healthcare Provider INSTRUCTIONS FOR USE TABLE OF CONTENTS Introduction...3 InPen Mobile App...3 Intended Use...3 Indications for Use...3 Contraindications...3 Start Orders...4 General
More informationBLINDED MODE USERS GUIDE SUPPLEMENT
BLINDED MODE USERS GUIDE SUPPLEMENT BLINDED MODE user s guide SUPPLEMENT WARNING: The SEVEN PLUS when set to Blinded Mode using the Data Manager Software will not provide real-time continuous glucose readings,
More informationJanuary 2017 Investor Presentation. confidently live life with ease
January 2017 Investor Presentation confidently live life with ease Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that could
More informationINSPIRED BY GIVE HIM MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs.
INSPIRED BY GIVE HIM MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs. * NOW APPROVED FOR AGES 7 AND UP. Waterproof to a depth
More informationCONTINUOUS GLUCOSE MONITORING SYSTEM USER S GUIDE
CONTINUOUS GLUCOSE MONITORING SYSTEM USER S GUIDE CONTINUOUS GLUCOSE MONITORING SYSTEM IMPORTANT CONTACTS AND NUMBERS Dexcom Website: www.dexcom.com Your Transmitter ID: Your Receiver ID: Your Healthcare
More informationInterpretation of Continuous Glucose Monitoring (CGM) Data
Interpretation of Continuous Glucose Monitoring (CGM) Data Sherri Horvat, BSN, RN, CDE Blood Glucose Manager, Animas Corporation A Johnson & Johnson Diabetes Care Company Overview of CGM Continuous glucose
More informationCanaccord Growth Conference August confidently live life with ease
Canaccord Growth Conference August 2018 confidently live life with ease Forward-Looking Statements This presentation contains forward-looking statements that are not purely historical regarding Senseonics
More informationAdvances in Diabetes Care Technologies
1979 Advances in Diabetes Care Technologies 2015 Introduction Roughly 20% - 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the US FDA estimated
More informationUser s Manual FLASH GLUCOSE MONITORING SYSTEM. CAUTION: Federal law restricts this device to sale by or on the order of a physician.
4.6 4.6 Distributed by: Abbott Diabetes Care Inc. 1360 South Loop Road Alameda, CA 94502 USA Customer Service: 1-855-632-8658 Monday through Friday, 8AM to 8PM Eastern Standard Time www.freestylelibre.com
More informationNow you know. InPen MOBILE APP. Healthcare Provider INSTRUCTIONS FOR USE. CompanionMedical.com Companion Medical, Inc.
InPen MOBILE APP Healthcare Provider INSTRUCTIONS FOR USE 2017 Companion Medical, Inc. LBL-00235-AC TABLE OF CONTENTS Introduction...3 InPen Mobile App...3 Intended Use...3 Indications for Use...3 Contraindications...3
More informationPOPULATION TRACKER - DREAMED USER GUIDE
POPULATION TRACKER - DREAMED USER GUIDE November 2018 IFU-0011 05 TABLE OF CONTENTS TABLE OF CONTENTS GENERAL INFORMATION... 1 Product Description... 1 Glooko Intended Use... 1 DreaMed Intended Use...
More informationDIABETES & ENDOCRINE DIABETES TECHNOLOGY: HOW TO STAY CURRENT WITH ONGOING TECHNOLOGY ADVANCEMENT
DIABETES TECHNOLOGY: HOW TO STAY CURRENT WITH ONGOING TECHNOLOGY ADVANCEMENT Min-Jye Chen, MD Endocrinology Diabetes Management of the School-Aged Child Provided by Texas Children s Hospital Provider #18-267764-A
More informationContinuous Glucose Monitoring System. User Guide
Continuous Glucose Monitoring System User Guide WARNING: Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use and all indications,
More informationPeople with type 1 diabetes and Do It Yourself (DIY) technology solutions ABOUT THIS POSITION STATEMENT
Position Statement People with type 1 diabetes and Do It Yourself (DIY) technology solutions ABOUT THIS POSITION STATEMENT Diabetes Australia believes that people with diabetes should have choice and access
More informationssociation of Children s Diabetes Clinicians Clinicians Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients
ssociation of Children s Diabetes Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients 1 ssociation of Children s Diabetes Contents Chapter Page no. STEP 1...3 Getting
More informationUser Guide. for Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System
User Guide for Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System IMPORTANT CONTACTS AND NUMBERS Emergency Phone Number: Your Healthcare Professional: Your Receiver Serial Number: Your Transmitter
More informationMINIMED 640G SYSTEM^ Getting Started WITH CONTINUOUS GLUCOSE MONITORING
MINIMED 640G SYSTEM^ Getting Started WITH CONTINUOUS GLUCOSE MONITORING let s get started! Table of Contents Section 1: Continuous Glucose Monitoring System Components... 2 Section 2: Sensor Glucose (SG)
More informationThe Current Environment of CGM Technologies. Barry H. Ginsberg, M.D., Ph.D.
Journal of Diabetes Science and Technology Volume 1, Issue 1, January 2007 Diabetes Technology Society SYMPOSIUM The Current Environment of CGM Technologies Introduction Barry H., M.D., Ph.D. This presentation
More informationQUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?
500 1 QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3? WHAT ADDITIONAL DATA ARE NEEDED? AACE/ACE CGM Consensus Conference:
More informationUSING THE MINIMED 670G SYSTEM. Instructions for the Experienced MiniMed 630G System User
USING THE MINIMED 670G SYSTEM Instructions for the Experienced MiniMed 630G System User This is a supplemental guide. For complete instructions and safety information, please see your MiniMed 670G System
More informationUSING THE MINIMED 670G SYSTEM
USING THE MINIMED 670G SYSTEM Instructions for the Experienced MiniMed 630G System User USING THE MINIMED 670G SYSTEM: INSTRUCTIONS FOR THE EXPERIENCED USER Checklist for starting on your MiniMed 670G
More informationReal-Time Continuous Glucose Monitoring: From Application to Evaluation
Real-Time Continuous Glucose Monitoring: From Application to Evaluation Gary Scheiner MS, CDE Owner/Director, Integrated Diabetes Services 333 E. Lancaster Ave., Suite 24 Wynnewood, PA 1996 (877) 735-3648
More informationI trust you are well, it is pleasing to see that your campaign is providing positive results.
Travelers on insulin pump therapy should always remove their insulin pump, sensor, transmitter, and meter before entering a room that has x-ray, magnetic resonance imaging (MRI), diathermy, or CT scan
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationFreeStyle Libre for glucose monitoring: Interim Position Statement for GPs & Patient FAQ
North Central London Joint Formulary Committee FreeStyle Libre for glucose monitoring: Interim Position Statement for GPs & Patient FAQ GPs should not prescribe FreeStyle Libre sensors on the NHS until
More informationData Management System (DMS) User Guide
Data Management System (DMS) User Guide Eversense and the Eversense logo are trademarks of Senseonics, Incorporated. Other brands and their products are trademarks or registered trademarks of their respective
More informationContinuous Glucose Monitors for Diabetes Management
Continuous Glucose Monitors for Diabetes Management Ryan Huang, DO PGY II, Sonia Garcia-Jayne, DO PGY II Mandeep Gill, DO PGY I, Justin Leeka, DO, PGY I, Catherine Nguyen OMS IV Family Medicine Residency,
More informationDexcom G4 CONTINUOUS GLUCOSE MONITORING SYSTEM USER S GUIDE
Dexcom G4 CONTINUOUS GLUCOSE MONITORING SYSTEM USER S GUIDE Dexcom G4 CONTINUOUS GLUCOSE MONITORING SYSTEM IMPORTANT CONTACTS AND NUMBERS Dexcom Website: www.dexcom.com Your Transmitter ID: Your Receiver
More informationCoverage and Coding of Continuous Glucose Monitors
Coverage and Coding of Continuous Glucose Monitors Length: 15:43 Date Recorded: 3.15.17 Hello and welcome to another edition of Medicare Minute MD. I m Dr. Robert Hoover, medical director at CGS Administrators,
More informationDIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)
Type 2 Diabetes DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) Clinical Guideline Self-monitoring of blood glucose (SMBG) should be considered but not be routinely offered for adults with type 2 diabetes
More informationCONTINUOUS GLUCOSE MONITORING SYSTEM USER S GUIDE
CONTINUOUS GLUCOSE MONITORING SYSTEM USER S GUIDE USER S GUIDE DEXCOM G4 PLATINUM PROFESSIONAL CONTINUOUS GLUCOSE MONITORING SYSTEM IMPORTANT CONTACTS AND NUMBERS Dexcom Website: www.dexcom.com The Transmitter
More informationContinuous Glucose Monitoring (CGM)
Continuous Glucose Monitoring (CGM) Date of Origin: 02/2001 Last Review Date: 07/26/2017 Effective Date: 07/26/2017 Dates Reviewed: 04/2004, 04/2005, 03/2006, 11/2006, 12/2007, 03/2008, 09/2008, 04/2009,
More informationEarly Patient and Clinician Experiences with Continuous Glucose Monitoring
Feature Article / Early Experiences with CGM Early Patient and Clinician Experiences with Continuous Glucose Monitoring David K. Bloomgarden, MD, FACE; Janine Freeman, RD, LD, CDE; and Elizabeth DeRobertis,
More informationGLOOKO FOR ios MIDS USER GUIDE
GLOOKO FOR ios MIDS USER GUIDE October 2018 IFU-0001 13 Glooko MIDS is cleared for US only Rx only TABLE OF CONTENTS TABLE OF CONTENTS MOBILE INSULIN DOSING SYSTEM (MIDS)... 2 Intended Use... 2 Warnings...
More information